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RESPONSE TO LETTER TO THE EDITOR
Response to ‘‘Treatment compliance and effectiveness
in complex PTSD patients with co-morbid personality
disorder undergoing stabilizing cognitive behavioral
group treatment: a preliminary study’’  authors’ reply
I
n a response to our article ‘‘Treatment compliance
and effectiveness in complex PTSD patients with
personality disorders (... )’’ (Dorrepaal et al., 2013),
Dr. A de Jongh and Dr. E ten Broeke express their
concern ‘‘that conclusions on data derived from an
analysis of a sample of complex PTSD patients pre-
viously published in the Journal of Psychosomatics and
Psychotherapy (Dorrepaal, et al., 2012), could prema-
turely encourage clinicians, as well as investigators,
to offer their patients similar stabilization programs
in affiliated mental health institutions.’’ In this reply,
we would like to explain what we actually encourage
clinicians and researchers to do, and why: 1) stabilize
when PTSD patients drop-out from, or cannot be
included in, first-line treatments due to complexity and
comorbidity; 2) conduct treatment effect studies on
complex PTSD patients with comorbid severe personality
disorder(s) (PD) before generalizing the effectiveness of
first-line treatments to this understudied group; and 3)
use stabilization treatment to prepare complex PTSD
patients with comorbid PD for first-line treatments and
as such increase the net number of patients profiting from
these treatments.
De Jongh and ten Broeke question the conclusions that
we drew from our data, citing ‘‘while significant super-
iority on change scores was absent, responder analysis
suggested clinical meaningfulness of adding group treat-
ment.’’ As we reported in the article describing our
clinical trial that they referred to (Dorrepaal et al., 2012),
our results were ambiguous and were described accord-
ingly. The authors appear to have misread our conclu-
sions as being based on an analysis of patients
completing treatment only, whereas they were based on
intention-to-treat (ITT) analyses as well as analyses of
completers (Dorrepaal et al., 2012, tables 34). Change
scores were significant at trend level only, probably
because we based our power calculation on Zlotnick
et al.’s (1997) randomized controlled trial. These authors
found a very low effect size in their treatment as usual
comparison condition (TAU: d0.1), while TAU in our
trial achieved a medium effect size. Had we initially based
the power of our study on a medium effect size within
TAU, almost double the number of patients would have
been required to demonstrate significant results. Alter-
natively, we could have applied a more powerful one-
tailed test to our data, which would have yielded
statistically significant results as well. Importantly, the
secondary responders’ analysis on PTSD symptoms (ITT;
p0.03) was statistically significant and indicated
clinical meaningfulness. Moreover, our results are sup-
ported by our neuroimaging study showing improvement
in terms of increased selective attention and decreased
emotional arousal, associated with normalized activation
in the dorsal anterior cingulate cortex and anterior insula
after adding stabilizing treatment (Thomaes et al., 2012).
Therefore, we do not agree that our carefully phrased
conclusion of ‘‘clinical meaningfulness’’ is an overstate-
ment of the effectiveness of the intervention, especially in
this population.
We agree with De Jongh and ten Broeke’s concern that
‘‘the effect of (the experimental treatment) over TAU
could be considered as ‘placebo effects’’’, since our design
did not include a comparison to a gold standard
treatment or placebo (Dorrepaal et al., 2012). However,
we disagree with their suggestion that the effect of the
treatment over TAU may have been caused by sponta-
neous improvement or symptom fluctuation as these
would likely affect both conditions, which is obviously
the reason to compare such conditions in a controlled
trial. Moreover, regression to the mean cannot explain
the difference between conditions in our trial, since high
symptomatic patients and low symptomatic patients
profited equally from the treatment.
DeJonghandtenBroekeconsideredtheattritionrateto
be relatively high (althoughthey misreadthe attrition rate,
which was 16% in the total group of 71 patients described
in Dorrepaal et al., 2012, 18% in the subgroup of 38
patients receiving the stabilizing treatment described in
Dorrepaal et al., 2013, and 15% in the subgroup of 33
patientsreceivingTAU).However,ourattritionrateinthis
complex population is similar to, and not higher than,
the mean attrition reported previously for various PTSD
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(page number not for citation purpose)populations and treatments (Bradley, Greene, Russ,
Dutra, & Westen, 2005; Foa, Keane, Friedman, & Cohen,
2009). Moreover, post-hoc, our complex PTSD patients
with a PD actually showed much lower drop-out rates
(10%), even lower than drop-out rates in specific PD
treatments, which range from 25 to 51% (Doering et al.,
2010). As we argued in our discussion, PTSD patients
without PDs (the less severe, smaller part of our popula-
tion), showed the highest drop-out rate (44%). This may
indicate that they do not need extensive stabilization,
which is in line with a phase-based approach.
Contrary to what De Jongh and ten Broeke assume,
none of the group therapists were replaced during the 20-
week group intervention. However, many group thera-
pists were comparatively inexperienced in conducting the
treatment protocol, which may have resulted in an
underestimation of the potential treatment effect.
There is a knowledge gap with respect to effective
treatment of complex PTSD patients with PD, because
this subgroup is rarely included in studies of exposure-
based treatment. This limits the generalizability of
previous research to this population which arguably is
in greater need of treatment (Bradley, Greene, Russ,
Dutra, & Westen, 2005). Furthermore, we found some
evidence that affect management (‘‘stabilization’’) results
in better outcomes than exposure treatment in complex
PTSD, whether calculated in terms of drop-out, recovery,
or improvement rates (meta-analysis, Dorrepaal et al.,
submitted). Interestingly, ten Broeke and de Jongh
themselves included an important chapter on stabiliza-
tion in their Handbook of EMDR where they advise on
how to prepare PTSD patients for EMDR treatment
(2013). To date, there is no outcome study directly
comparing stabilization to EMDR in the treatment of
child abuse related complex PTSD with severe PD. These
treatments were compared in a small randomized con-
trolled trial conducted by de Jongh and ten Broeke in a
fairly complex patient population, but no assessment of
child abuse, complex PTSD or PDs was reported (Ter
Heide, Mooren, Kleijn, de Jongh, & Kleber, 2011). Based
on their completers’ analysis of five patients per arm with
a drop-out rate of 50%, they concluded that improvement
on EMDR was small, but not worse than stabilization
and that further comparison is needed.
The content of our time-limited ‘‘stabilizing’’ treatment
protocol largely overlaps with other (effective) evidence-
based stabilizing treatments (Cloitre et al., 2010; Zlotnick
et al., 1997) and cognitive (processing) therapy (Resick
et al., 2008) for PTSD, as well as with the recent use
of dialectical behavior therapy for borderline PD with
PTSD (Harned, Jackson, Comtois, & Linehan, 2010).
This should encourage clinicians, as well as investigators,
to offer their patients similar stabilization programs
as ours, after which many patients are able to enter
exposure-based treatments. Interventions that directly
target general emotion-regulation skills enhance the
effectiveness of psychotherapeutic cognitive (processing)
therapy interventions (Berking et al., 2008).
In conclusion, the findings in our paper ‘‘Treatment
compliance and effectiveness in complex PTSD patients
with co-morbid personality disorder’’ (Dorrepaal et al.,
2013) support stabilization in child abuserelated PTSD
with PD, whereas our stabilizing treatment is not well
suited to patients without PD. Although change score
differences did not show a statistically significant super-
iorityforstabilization,resultsofthesecondaryresponders’
analyses were statistically significant and implied the
clinical meaningfulness of combining skills training with
cognitive therapy. Moreover, we demonstrated a very low
drop-out rate in complex PTSD patients with PDs. There-
fore, we recommend the use of stabilization treatment
when PTSD patients drop out or cannot be included in
evidence-based treatments like EMDR, prolonged expo-
sureandcognitive(processing)therapyduetocomplexities
such as severe personality disturbances. This conclusion is
provisionalonothertreatmentsnothavingshownsuperior
results in this population. We agree with de Jongh and
ten Broeke that more research is needed with head-to-
head comparisons in PTSD samples, particularly those
consisting of complex PTSD, poorly educated, non-white,
unemployed, medicated, suicidal, and personality dis-
turbed individuals who have not responded to previous
treatment, like the patients in our study. This is essential
before assuming the effectiveness of any treatments in this
understudied subgroup.
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